These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 35406803)

  • 1. Microglial Endocannabinoid Signalling in AD.
    Scipioni L; Ciaramellano F; Carnicelli V; Leuti A; Lizzi AR; De Dominicis N; Oddi S; Maccarrone M
    Cells; 2022 Apr; 11(7):. PubMed ID: 35406803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease.
    Rapaka D; Bitra VR; Challa SR; Adiukwu PC
    Neuropeptides; 2021 Dec; 90():102196. PubMed ID: 34508923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ Chronic Exposure Promotes an Activation State of Microglia through Endocannabinoid Signalling Imbalance.
    Scipioni L; Tortolani D; Ciaramellano F; Fanti F; Gazzi T; Sergi M; Nazaré M; Oddi S; Maccarrone M
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview on microglial origin, distribution, and phenotype in Alzheimer's disease.
    Islam R; Choudhary H; Rajan R; Vrionis F; Hanafy KA
    J Cell Physiol; 2024 Jun; 239(6):e30829. PubMed ID: 35822939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microglial polarization: novel therapeutic mechanism against Alzheimer's disease.
    Yao K; Zu HB
    Inflammopharmacology; 2020 Feb; 28(1):95-110. PubMed ID: 31264132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers.
    Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D
    J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's Disease.
    Keaney J; Gasser J; Gillet G; Scholz D; Kadiu I
    J Neuroimmune Pharmacol; 2019 Sep; 14(3):448-461. PubMed ID: 30758770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.
    Qu W; Li L
    Neuroscientist; 2023 Jun; 29(3):302-316. PubMed ID: 34470515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics.
    Lepiarz-Raba I; Gbadamosi I; Florea R; Paolicelli RC; Jawaid A
    Transl Neurodegener; 2023 Oct; 12(1):48. PubMed ID: 37908010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia in Alzheimer's Disease: A Favorable Cellular Target to Ameliorate Alzheimer's Pathogenesis.
    Sumsuzzman DM; Uddin MS; Kabir MT; Hasana S; Perveen A; Alanazi IS; Albadrani GM; Abdel-Daim MM; Ashraf GM
    Mediators Inflamm; 2022; 2022():6052932. PubMed ID: 35693110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies.
    Sun Z; Zhang X; So KF; Jiang W; Chiu K
    Biomolecules; 2024 Jul; 14(7):. PubMed ID: 39062547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of plant-derived natural compounds in Alzheimer's disease: Targeting microglia-mediated neuroinflammation.
    Shen Y; Liu F; Zhang M
    Biomed Pharmacother; 2024 Sep; 178():117235. PubMed ID: 39094545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglial modulation as a therapeutic strategy in Alzheimer's disease: Focus on microglial preconditioning approaches.
    Yassaghi Y; Nazerian Y; Ghasemi M; Nazerian A; Sayehmiri F; Perry G; Gholami Pourbadie H
    J Cell Mol Med; 2024 Aug; 28(15):e18554. PubMed ID: 39103747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How brain 'cleaners' fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer's disease.
    Ni J; Xie Z; Quan Z; Meng J; Qing H
    Glia; 2024 Feb; 72(2):227-244. PubMed ID: 37650384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
    Streit WJ; Braak H; Xue QS; Bechmann I
    Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain resident microglia in Alzheimer's disease: foe or friends.
    Kaur S; K M; Sharma A; Giridharan VV; Dandekar MP
    Inflammopharmacology; 2024 Oct; 32(5):2781-2800. PubMed ID: 39167311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia in Alzheimer's disease: the good, the bad and the ugly.
    Tejera D; Heneka MT
    Curr Alzheimer Res; 2016; 13(4):370-80. PubMed ID: 26567746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
    Kaur D; Sharma V; Deshmukh R
    Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.